Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Aptevo Therapeutics Inc APVO

Healthcare Biotechnology
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human... see more

Current News (NDAQ:APVO)

Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth

ACCESS Newswire 11 days ago

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality

ACCESS Newswire January 9, 2026

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

ACCESS Newswire December 26, 2025

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

ACCESS Newswire December 9, 2025

Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors

ACCESS Newswire November 10, 2025

Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

ACCESS Newswire November 6, 2025

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

ACCESS Newswire October 8, 2025

Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML

ACCESS Newswire September 16, 2025

Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules

ACCESS Newswire September 4, 2025
View More News ››

Opinion & Analysis (NDAQ:APVO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:APVO)

RE:RE:APVO.....WTF ? $10.65 on Low Volume...seriously?

APVO update......I sold my small position yesterday. Sorry for the late post. Now at $8.39 on low vol I may return at a later date and...
Iseneschal - January 27, 2026

RE:APVO.....WTF ? $10.65 on Low Volume...seriously?

Low of $8.90 this a.m....Time to re-load? Small position started ; )
Iseneschal - January 21, 2026

APVO.....WTF ? $10.65 on Low Volume...seriously?

Sell em if ya gottem
Iseneschal - January 20, 2026

RE:APVO.....I'd say this will be bleeding all next week

Ok ...all kidding aside.....I will stand by this. It's 01/09/25 Friday with 10 mins til the close Let's see where all this...
Iseneschal - January 9, 2026

APVO..... Thanks for the excellent scalp

The whole time I was talkin smack was all Bull excrement.... Cheers ! Sold all just shy of the 2x's tap at $9.81 Happy Fryday...
Iseneschal - January 9, 2026

APVO....Time for the "Rug Pull" ?

I'd say so
Iseneschal - January 9, 2026
View more Bullboard ››

Walker Lane Resources Ltd.

Walker Lane Resources Ltd.

Walker Lane Resources Ltd. engages in the acquisition and exploration of mineral properties in Canada. The company explores ...
View More »

Podcasts